Akhil Khajuria
Papers
1
Total Citations
6
H-Index
1
About
Dr. Akhil Khajuria is a rising figure in nanomedicine and cancer theragnostics, whose work bridges the frontier between nanotechnology and targeted oncology. His most-cited paper, “A Path of Novelty from Nanoparticles to Nanobots: Theragnostic Approach for Targeting Cancer Therapy” (2023, 6 citations), charts a visionary trajectory from conventional nanoparticle-based drug delivery to the emerging potential of nanobots for simultaneous diagnosis and therapy. In this work, Dr. Khajuria critically analyzes how nanotechnology can overcome the longstanding limitations of conventional cancer treatments—such as poor bioavailability, systemic toxicity, and drug resistance—by enabling precise, stimuli-responsive delivery systems. His research emphasizes the integration of diagnostic imaging with therapeutic action, a paradigm that promises to personalize cancer care. While his citation count reflects the early stage of his career, the conceptual boldness of his work signals a significant contribution to the field. Dr. Khajuria’s scholarship serves as a compelling roadmap for students and researchers interested in the next generation of smart, multifunctional nanocarriers that could one day transform cancer from a devastating diagnosis into a manageable condition.
Research Focus
Key Achievements
Top Papers
- 1